CDK6 and pancreatic neoplasm: The results demonstrated that silencing circSEC24A expression resulted in protein downregulation of CDK4, CDK6 and Cyclin D1, indicating that inhibited circSEC24A could negatively modulate pancreatic cancer cell proliferation (Fig. 2I).